Medicare Enrolled
Dr. Jun Lee, M.D
Rheumatology · Flushing, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Jun Lee is a rheumatology specialist in Flushing, NY, with 11 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 8,375 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lee received a total of $1,800 from 16 pharmaceutical and/or device companies across 108 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 18% volume in NY
$1,800 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,375
Medicare services
Top 18% in NY for rheumatology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
651 | $104 | $214 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
441 | $18 | $79 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
299 | $4 | $11 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
291 | $5 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
285 | $8 | $12 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
265 | $8 | $37 |
| Liver function blood test panel | 240 | $8 | $32 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
240 | $7 | $28 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
140 | $11 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
124 | $138 | $261 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
100 | $12 | $68 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
100 | $66 | $307 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
95 | $120 | $248 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
84 | $1 | $30 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
71 | $13 | $57 |
| Rheumatoid factor level | 70 | $6 | $25 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
64 | $12 | $53 |
| Measurement of dna antibody, single stranded | 64 | $12 | $53 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
63 | $13 | $60 |
| Beta 2 glycoprotein 1 antibody (autoantibody) measurement | 57 | $25 | $112 |
| Cardiolipin antibody (tissue antibody) measurement | 57 | $25 | $110 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
55 | $29 | $130 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
54 | $7 | $22 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
50 | $10 | $16 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
46 | $92 | $154 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $73 | $129 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
30 | $12 | $53 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $5 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
19 | $4 | $8 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
18 | $6 | $29 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $6 | $30 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
13 | $61 | $272 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
11 | $36 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.1% high complexity
53.3% medium
44.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,800
Total received (2020-2024)
Avg $360/year across 5 years
Bottom 47% in NY for rheumatology
16
Companies
108
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$676
2023
$700
2022
$354
2021
$55
2020
$14
Payments by company (2024)
ABBVIE INC.
$178
AstraZeneca Pharmaceuticals LP
$119
UCB, Inc.
$96
Novartis Pharmaceuticals Corporation
$86
Janssen Biotech, Inc.
$63
Organon Llc
$42
Amgen Inc.
$42
GlaxoSmithKline, LLC.
$30
Mallinckrodt Hospital Products Inc.
$20
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2020-2024) ›
Amgen Inc.
$347
Novartis Pharmaceuticals Corporation
$321
ABBVIE INC.
$284
UCB, Inc.
$209
Janssen Biotech, Inc.
$163
AstraZeneca Pharmaceuticals LP
$159
Horizon Therapeutics plc
$74
GlaxoSmithKline, LLC.
$43
Organon Llc
$42
E.R. Squibb & Sons, L.L.C.
$41
PFIZER INC.
$29
Pacira Pharmaceuticals Incorporated
$24
Mallinckrodt Hospital Products Inc.
$20
GENZYME CORPORATION
$17
SANOFI-AVENTIS U.S. LLC
$15
Organon LLC
$12
Top 3 companies account for 52.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · HADLIMA · Iovera · KEVZARA · KRYSTEXXA · ORENCIA · RENFLEXIS · RINVOQ · SAPHNELO · SKYRIZI · SYNVISC-ONE · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
379
County median income
$84,961
Nearest hospital to ZIP centroid (approximate)
NEW YORK-PRESBYTERIAN/QUEENS
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a mixed practice specialist, with above-average Medicare volume (top 18% in NY).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lee performed 4,200 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $1,800 from 16 companies across 108 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other rheumatologists in Flushing?
Dr. Lee's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Flushing
Browse rheumatologists in Flushing ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology